Revolutions Medical Signs Distribution Agreement With McKesson

Revolutions Medical Signs Distribution Agreement With McKesson 
CHARLESTON, SC -- (Marketwire) -- 11/16/12 --  Revolutions Medical
Corporation (OTCQB: RMCP) announced today that the Company has
entered into a vendor and distribution agreement with McKesson
Corporation ("McKesson") for the distribution of the Company's
RevVac(TM) auto-retractable vacuum safety syringe in the United
States healthcare market. McKesson is one of the leading
medical-surgical supply and distribution companies in the United
States, while also serving as one of the country's largest
pharmaceutical distributors, supplying more than 40,000 pharmacy
locations across the U.S. Pursuant to the terms of the vendor and
distribution agreement, the RevVac(TM) auto-retractable vacuum safety
syringe is now available to over 550 McKesson sales representatives
through their distribution network and order processing system. 
Ron Wheet, the Company's Chief Executive Officer and Chairman,
stated, "Since introducing the RevVac(TM) safety syringe to the U.S.
health care market in the second quarter 2012, the Company has
considered several available options to best manage the roll out of
our product. We are very pleased to have the RevVac(TM) safety
syringe distributed by McKesson, one of the best names in health care
quality in the world. We believe this relationship will complement
our additional sales efforts with MedPro Associates." 
About Revolutions Medical Corporation 
Revolutions Medical Corporation is a safety medical device and
software application company. Its proprietary technologies and
products include: the RevVac(TM) safety syringe, safety blood drawing
device, the RevColor(TM), RevDisplay(TM), and Rev3D(TM) software
tools that are compatible with standard MRIs and standard Picture
Archiving Computer Systems (PACS) and prefilled vacuum
auto-retraction safety syringes. 
For additional information, please visit Revolutions Medical
corporate website: 
 http://www.revolutionsmedical.com/ 
To be added to the Revolutions Medical investor email list, please
email:
 investment@revolutionsmedical.com with RMCP in the subject
line. 
FORWARD-LOOKING STATEMENTS 
The information contained herein includes forward-looking statements.
These statements relate to future events or to our future financial 
performance, and involve known and unknown risks, uncertainties and
other factors that may cause our actual results, levels of activity,
performance, or achievements to be materially different from any
future results, levels of activity, performance or achievements
expressed or implied by these forward-looking statements. You should
not place undue reliance on forward-looking statements since they
involve known and unknown risks, uncertainties and other factors
which are, in some cases, beyond our control and which could, and
likely will, materially affect actual results, levels of activity,
performance or achievements. Any forward-looking statement reflects
our current views with respect to future events and is subject to
these and other risks, uncertainties and assumptions relating to our
operations, results of operations, growth strategy and liquidity. We
assume no obligation to publicly update or revise these
forward-looking statements for any reason, or to update the reasons
actual results could differ materially from those anticipated in
these forward-looking statements, even if new information becomes
available in the future. 
CONTACT:  
Revolutions Medical Corporation
Investor Relations
Tel.: (843) 606-9461 
 
 
Press spacebar to pause and continue. Press esc to stop.